Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The molecular genetics of sideroblastic anemia.

Ducamp S, Fleming MD.

Blood. 2019 Jan 3;133(1):59-69. doi: 10.1182/blood-2018-08-815951. Epub 2018 Nov 6. Review.

PMID:
30401706
2.

Finely-tuned regulation of AMP-activated protein kinase is crucial for human adult erythropoiesis.

Ladli M, Richard C, Aguilar LC, Ducamp S, Bondu S, Sujobert P, Tamburini J, Lacombe C, Azar N, Foretz M, Zermati Y, Mayeux P, Viollet B, Verdier F.

Haematologica. 2019 May;104(5):907-918. doi: 10.3324/haematol.2018.191403. Epub 2018 Oct 11.

3.

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.

Park S, Kosmider O, Maloisel F, Drenou B, Chapuis N, Lefebvre T, Karim Z, Puy H, Alary AS, Ducamp S, Verdier F, Bouilloux C, Rousseau A, Jacob MC, Debliquis A, Charpentier A, Gyan E, Anglaret B, Leyronnas C, Corm S, Slama B, Cheze S, Laribi K, Amé S, Rose C, Lachenal F, Toma A, Pica GM, Carre M, Garban F, Mariette C, Cahn JY, Meunier M, Herault O, Fenaux P, Wagner-Ballon O, Bardet V, Dreyfus F, Fontenay M.

Haematologica. 2019 Mar;104(3):497-504. doi: 10.3324/haematol.2018.203158. Epub 2018 Oct 4.

4.

Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria.

Yien YY, Ducamp S, van der Vorm LN, Kardon JR, Manceau H, Kannengiesser C, Bergonia HA, Kafina MD, Karim Z, Gouya L, Baker TA, Puy H, Phillips JD, Nicolas G, Paw BH.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E8045-E8052. doi: 10.1073/pnas.1700632114. Epub 2017 Sep 5.

5.

Qualitative and Semiquantitative Assessment of Exposure to Engineered Nanomaterials within the French EpiNano Program: Inter- and Intramethod Reliability Study.

Guseva Canu I, Jezewski-Serra D, Delabre L, Ducamp S, Iwatsubo Y, Audignon-Durand S, Ducros C, Radauceanu A, Durand C, Witschger O, Flahaut E.

Ann Work Expo Health. 2017 Jan 1;61(1):87-97. doi: 10.1093/annweh/wxw008.

PMID:
28395313
6.

Comprehensive Proteomic Analysis of Human Erythropoiesis.

Gautier EF, Ducamp S, Leduc M, Salnot V, Guillonneau F, Dussiot M, Hale J, Giarratana MC, Raimbault A, Douay L, Lacombe C, Mohandas N, Verdier F, Zermati Y, Mayeux P.

Cell Rep. 2016 Aug 2;16(5):1470-1484. doi: 10.1016/j.celrep.2016.06.085. Epub 2016 Jul 21.

7.

Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.

Fratz EJ, Clayton J, Hunter GA, Ducamp S, Breydo L, Uversky VN, Deybach JC, Gouya L, Puy H, Ferreira GC.

Biochemistry. 2015 Sep 15;54(36):5617-31. doi: 10.1021/acs.biochem.5b00407. Epub 2015 Sep 2.

8.

Co-exposure to refractory ceramic fibres and asbestos and risk of pleural mesothelioma.

Lacourt A, Rinaldo M, Gramond C, Ducamp S, Gilg Soit Ilg A, Goldberg M, Pairon JC, Brochard P.

Eur Respir J. 2014 Sep;44(3):725-33. doi: 10.1183/09031936.00079814. Epub 2014 Jul 17.

9.

Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.

Oustric V, Manceau H, Ducamp S, Soaid R, Karim Z, Schmitt C, Mirmiran A, Peoc'h K, Grandchamp B, Beaumont C, Lyoumi S, Moreau-Gaudry F, Guyonnet-Dupérat V, de Verneuil H, Marie J, Puy H, Deybach JC, Gouya L.

Am J Hum Genet. 2014 Apr 3;94(4):611-7. doi: 10.1016/j.ajhg.2014.02.010. Epub 2014 Mar 27.

10.

[The French mesothelioma network from 1998 to 2013].

Galateau-Sallé F, Gilg Soit Ilg A, Le Stang N, Brochard P, Pairon JC, Astoul P, Frenay C, Blaizot G, Chamming's S, Ducamp S, Rousvoal T, de Quillacq A, Abonnet V, Abdalsamad I, Begueret H, Brambilla E, Capron F, Copin MC, Danel C, de Lajartre AY, Foulet-Roge A, Garbe L, Groussard O, Giusiano S, Hofman V, Lantuejoul S, Piquenot JM, Rouquette I, Sagan C, Thivolet-Bejui F, Vignaud JM, Scherpereel A, Jaurand MC, Jean D, Hainaut P, Chérié-Challine L, Goldberg M, Luce D, Imbernon E.

Ann Pathol. 2014 Feb;34(1):51-63. doi: 10.1016/j.annpat.2014.01.009. Epub 2014 Feb 26. French.

11.

Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma.

Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, Chamming's S, Gilg Soit Ilg A, Rinaldo M, Raherison C, Galateau-Salle F, Imbernon E, Pairon JC, Goldberg M, Brochard P.

Thorax. 2014 Jun;69(6):532-9. doi: 10.1136/thoraxjnl-2013-203744. Epub 2014 Feb 7.

PMID:
24508707
12.

Risk of lung cancer associated with occupational exposure to mineral wools: updating knowledge from a french population-based case-control study, the ICARE study.

Guida F, Paget-Bailly S, Lamkarkach F, Gaye O, Ducamp S, Menvielle G, Papadopoulos A, Matrat M, Févotte J, Cénée S, Cyr D, Schmaus A, Carton M, Radoï L, Lapôtre-Ledoux B, Molinié F, Luce D, Stücker I.

J Occup Environ Med. 2013 Jul;55(7):786-95. doi: 10.1097/JOM.0b013e318289ee8b.

PMID:
23787568
13.

Pleural mesothelioma and occupational coexposure to asbestos, mineral wool, and silica.

Lacourt A, Gramond C, Audignon S, Ducamp S, Févotte J, Soit Ilg AG, Goldberg M, Imbernon E, Brochard P.

Am J Respir Crit Care Med. 2013 May 1;187(9):977-82. doi: 10.1164/rccm.201210-1911OC.

PMID:
23471464
14.

Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP).

Ducamp S, Schneider-Yin X, de Rooij F, Clayton J, Fratz EJ, Rudd A, Ostapowicz G, Varigos G, Lefebvre T, Deybach JC, Gouya L, Wilson P, Ferreira GC, Minder EI, Puy H.

Hum Mol Genet. 2013 Apr 1;22(7):1280-8. doi: 10.1093/hmg/dds531. Epub 2012 Dec 20.

PMID:
23263862
15.

Late-onset X-linked dominant protoporphyria: an etiology of photosensitivity in the elderly.

Livideanu CB, Ducamp S, Lamant L, Gouya L, Rauzy OB, Deybach JC, Paul C, Puy H, Marguery MC.

J Invest Dermatol. 2013 Jun;133(6):1688-90. doi: 10.1038/jid.2012.467. Epub 2012 Dec 6. No abstract available.

16.

Compensation of pleural mesothelioma in France: data from the French National Mesothelioma Surveillance Programme.

Chamming's S, Clin B, Brochard P, Astoul P, Ducamp S, Galateau-Salle F, Ilg AG, Goldberg M, Gramond C, Imbernon E, Rolland P, Pairon JC.

Am J Ind Med. 2013 Feb;56(2):146-54. doi: 10.1002/ajim.22106. Epub 2012 Aug 21.

PMID:
22911649
17.

Choice of rating method for assessing occupational asbestos exposure: study for compensation purposes in France.

Gramond C, Rolland P, Lacourt A, Ducamp S, Chamming's S, Creau Y, Hery M, Laureillard J, Mohammed-Brahim B, Orlowski E, Paris C, Pairon JC, Goldberg M, Brochard P; PNSM Study Group.

Am J Ind Med. 2012 May;55(5):440-9. doi: 10.1002/ajim.22008. Epub 2012 Jan 11.

18.

Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma.

Lacourt A, Leffondré K, Gramond C, Ducamp S, Rolland P, Gilg Soit Ilg A, Houot M, Imbernon E, Févotte J, Goldberg M, Brochard P.

Eur Respir J. 2012 Jun;39(6):1304-12. doi: 10.1183/09031936.00005111. Epub 2011 Nov 10.

19.

Matgéné: a program to develop job-exposure matrices in the general population in France.

Févotte J, Dananché B, Delabre L, Ducamp S, Garras L, Houot M, Luce D, Orlowski E, Pilorget C, Lacourt A, Brochard P, Goldberg M, Imbernon E.

Ann Occup Hyg. 2011 Oct;55(8):865-78. doi: 10.1093/annhyg/mer067. Epub 2011 Sep 15.

PMID:
21926066
20.

Occupational and residential exposure to electromagnetic fields and risk of brain tumors in adults: a case-control study in Gironde, France.

Baldi I, Coureau G, Jaffré A, Gruber A, Ducamp S, Provost D, Lebailly P, Vital A, Loiseau H, Salamon R.

Int J Cancer. 2011 Sep 15;129(6):1477-84. doi: 10.1002/ijc.25765. Epub 2011 Jan 12.

21.

ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.

To-Figueras J, Ducamp S, Clayton J, Badenas C, Delaby C, Ged C, Lyoumi S, Gouya L, de Verneuil H, Beaumont C, Ferreira GC, Deybach JC, Herrero C, Puy H.

Blood. 2011 Aug 11;118(6):1443-51. doi: 10.1182/blood-2011-03-342873. Epub 2011 Jun 7.

PMID:
21653323
22.

Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.

Ducamp S, Kannengiesser C, Touati M, Garçon L, Guerci-Bresler A, Guichard JF, Vermylen C, Dochir J, Poirel HA, Fouyssac F, Mansuy L, Leroux G, Tertian G, Girot R, Heimpel H, Matthes T, Talbi N, Deybach JC, Beaumont C, Puy H, Grandchamp B.

Hum Mutat. 2011 Jun;32(6):590-7. doi: 10.1002/humu.21455. Epub 2011 Feb 24.

PMID:
21309041
23.

Occupations and industries in France at high risk for pleural mesothelioma: A population-based case-control study (1998-2002).

Rolland P, Gramond C, Lacourt A, Astoul P, Chamming's S, Ducamp S, Frenay C, Galateau-Salle F, Ilg AG, Imbernon E, Le Stang N, Pairon JC, Goldberg M, Brochard P; PNSM Study Group.

Am J Ind Med. 2010 Dec;53(12):1207-19. doi: 10.1002/ajim.20895.

PMID:
20886529
24.

[Inheritance in erythropoietic protoporphyria].

Schmitt C, Ducamp S, Gouya L, Deybach JC, Puy H.

Pathol Biol (Paris). 2010 Oct;58(5):372-80. doi: 10.1016/j.patbio.2010.01.007. Epub 2010 Sep 20. Review. French.

PMID:
20850938
25.

Attributable risk in men in two French case-control studies on mesothelioma and asbestos.

Lacourt A, Rolland P, Gramond C, Astoul P, Chamming's S, Ducamp S, Frenay C, Galateau-Sallé F, Gilg Soit Ilg A, Imbernon E, Le Stang N, Pairon JC, Goldberg M, Iwatsubo Y, Salmi LR, Brochard P.

Eur J Epidemiol. 2010 Nov;25(11):799-806. doi: 10.1007/s10654-010-9502-0. Epub 2010 Sep 7.

PMID:
20821038
26.

Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.

Delaby C, Lyoumi S, Ducamp S, Martin-Schmitt C, Gouya L, Deybach JC, Beaumont C, Puy H.

Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):45-52.

PMID:
19268001
27.

C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H.

Am J Hum Genet. 2008 Sep;83(3):408-14. doi: 10.1016/j.ajhg.2008.08.003. Epub 2008 Sep 4.

28.

Severe pyogenic infections in patients taking infliximab: a regional cohort study.

Maillard H, Ornetti P, Grimault L, Ramon JF, Ducamp SM, Saidani T, Tavernier C, Maillefert JF.

Joint Bone Spine. 2005 Jul;72(4):330-4. Epub 2004 Oct 28.

PMID:
16038846
29.
30.

A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.

Simon N, Couroucé AM, Lemarrec N, Trépo C, Ducamp S.

Kidney Int. 1994 Aug;46(2):504-11.

31.

Similarity of the 5' and 3'-TAR secondary structures in HIV-1.

Wang P, Rouyez MC, Ducamp S, Saragosti S, Ventura M.

Biochem Biophys Res Commun. 1993 Sep 15;195(2):565-73.

PMID:
8373397
32.

[Computer-assisted diet therapy in pediatric kidney diseases].

Dartois AM, Ducamp S, Decaux F, Broyer M.

Pediatrie. 1989;44(3):197-202. French.

PMID:
2740188

Supplemental Content

Loading ...
Support Center